• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy of anakinra on rebound of multisystem inflammatory syndrome.

作者信息

Brisca Giacomo, Olcese Camilla, Derchi Maria Elena, Trocchio Gianluca, Caorsi Roberta, Moscatelli Andrea, Gattorno Marco

机构信息

Terapia Semintensiva, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI), Università degli Studi di Genova, Genoa, Italy.

出版信息

Pediatr Int. 2022 Jan;64(1):e15337. doi: 10.1111/ped.15337.

DOI:10.1111/ped.15337
PMID:36331228
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9828510/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5013/9828510/5ea836970b66/PED-64-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5013/9828510/5ea836970b66/PED-64-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5013/9828510/5ea836970b66/PED-64-0-g002.jpg

相似文献

1
Efficacy of anakinra on rebound of multisystem inflammatory syndrome.阿那白滞素对多系统炎症综合征复发的疗效。
Pediatr Int. 2022 Jan;64(1):e15337. doi: 10.1111/ped.15337.
2
SARS-CoV-2 multisystem inflammatory syndrome in an adult presenting with polyarthritis treated with anakinra.一名成年患者出现多关节炎，经阿那白滞素治疗的新型冠状病毒2型多系统炎症综合征。
Rheumatology (Oxford). 2022 Feb 2;61(2):e33-e34. doi: 10.1093/rheumatology/keab697.
3
Effectiveness of early Anakinra on cardiac function in children with multisystem inflammatory syndrome of COVID-19: a systematic review.COVID-19 相关多系统炎症综合征患儿早期使用阿那白滞素对心功能的疗效：系统评价。
BMC Infect Dis. 2024 Aug 21;24(1):847. doi: 10.1186/s12879-024-09581-w.
4
Anakinra in Refractory Multisystem Inflammatory Syndrome in Children (MIS-C).阿那白滞素治疗儿童难治性多系统炎症综合征（MIS-C）
Indian Pediatr. 2021 Oct 15;58(10):994-996. doi: 10.1007/s13312-021-2340-1.
5
Multisystem inflammatory syndrome in adults: A rare sequela of SARS-CoV-2 infection.成人多系统炎症综合征：一种罕见的 SARS-CoV-2 感染后遗症。
Int J Infect Dis. 2021 Jul;108:209-211. doi: 10.1016/j.ijid.2021.05.050. Epub 2021 May 24.
6
Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.儿童严重急性呼吸综合征冠状病毒 2 诱导的多系统炎症综合征的独特临床和免疫学特征。
J Clin Invest. 2020 Nov 2;130(11):5942-5950. doi: 10.1172/JCI141113.
7
Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study.儿童多系统炎症综合征采用阿那白滞素治疗的临床结局和安全性：一项单中心观察性研究。
Pediatr Rheumatol Online J. 2023 Jul 31;21(1):76. doi: 10.1186/s12969-023-00858-z.
8
The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center.单儿科风湿病中心中儿童多系统炎症综合征的临床病程和短期健康结局。
Postgrad Med. 2021 Nov;133(8):994-1000. doi: 10.1080/00325481.2021.1987732. Epub 2021 Oct 17.
9
Intravenous administration of anakinra in children with macrophage activation syndrome.静脉内给予阿那白滞素治疗儿童巨噬细胞活化综合征。
Pediatr Rheumatol Online J. 2021 Jun 29;19(1):98. doi: 10.1186/s12969-021-00585-3.
10
Extracorporeal Membrane Oxygenation for COVID-19-Associated Multisystem Inflammatory Syndrome in a 5-year-old.体外膜肺氧合治疗 5 岁儿童 COVID-19 相关多系统炎症综合征。
Am Surg. 2022 Feb;88(2):174-176. doi: 10.1177/0003134820983198. Epub 2020 Dec 29.

引用本文的文献

1
Case Report: Two episodes of hyperinflammation in an infant consistent with multisystem inflammatory syndrome in children: recurrence or rather two different diseases?病例报告：一名婴儿出现两期与儿童多系统炎症综合征相符的高度炎症：复发还是两种不同的疾病？
Front Pediatr. 2025 Jun 5;13:1559244. doi: 10.3389/fped.2025.1559244. eCollection 2025.
2
Incidence and Prevalence of Multisystem Inflammatory Syndrome in Children (MIS-C) in Southern Italy.意大利南部儿童多系统炎症综合征（MIS-C）的发病率和患病率
Children (Basel). 2023 Apr 23;10(5):766. doi: 10.3390/children10050766.

本文引用的文献

1
Timely Recognition and Early Multi-Step Antinflammatory Therapy May Prevent ICU Admission of Patients With MIS-C: Proposal for a Severity Score.及时识别和早期多步骤抗炎治疗可能预防儿童多系统炎症综合征患者入住重症监护病房：严重程度评分建议
Front Pediatr. 2021 Dec 20;9:783745. doi: 10.3389/fped.2021.783745. eCollection 2021.
2
Second Episode of Multisystem Inflammatory Syndrome in Children: Relapse, Rebound, or Recurrence?儿童多系统炎症综合征的第二阶段：复发、反弹还是再发？
Pediatr Infect Dis J. 2021 Nov 1;40(11):e452. doi: 10.1097/INF.0000000000003249.
3
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
美国儿童多系统炎症综合征（MIS-C）与严重急性 COVID-19 患儿的特征和结局比较。
JAMA. 2021 Mar 16;325(11):1074-1087. doi: 10.1001/jama.2021.2091.
4
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2.美国风湿病学会儿童与 SARS-CoV-2 相关的多系统炎症综合征和儿科 COVID-19 中过度炎症的临床指导：第 2 版。
Arthritis Rheumatol. 2021 Apr;73(4):e13-e29. doi: 10.1002/art.41616. Epub 2021 Feb 15.